nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.055	0.129	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0452	0.106	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0417	0.0978	CbGpPWpGaD
Misoprostol—PTGER2—trachea—thyroid cancer	0.0225	0.196	CbGeAlD
Misoprostol—PTGER4—G alpha (s) signalling events—CALCB—thyroid cancer	0.0219	0.0515	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—CALCB—thyroid cancer	0.018	0.0423	CbGpPWpGaD
Misoprostol—PTGER4—thyroid gland—thyroid cancer	0.0175	0.153	CbGeAlD
Misoprostol—PTGER4—head—thyroid cancer	0.0155	0.135	CbGeAlD
Misoprostol—PTGER3—thyroid gland—thyroid cancer	0.0148	0.129	CbGeAlD
Misoprostol—PTGER3—head—thyroid cancer	0.0131	0.115	CbGeAlD
Misoprostol—PTGER2—lymph node—thyroid cancer	0.011	0.0966	CbGeAlD
Misoprostol—PTGER4—lymph node—thyroid cancer	0.0108	0.0948	CbGeAlD
Misoprostol—PTGER4—G alpha (s) signalling events—TSHR—thyroid cancer	0.0102	0.0238	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00987	0.0232	CbGpPWpGaD
Misoprostol—Embolism—Sorafenib—thyroid cancer	0.0097	0.0211	CcSEcCtD
Misoprostol—PTGER3—lymph node—thyroid cancer	0.00918	0.0803	CbGeAlD
Misoprostol—PTGER2—G alpha (s) signalling events—TSHR—thyroid cancer	0.00834	0.0196	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.0081	0.019	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CALCB—thyroid cancer	0.00796	0.0187	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—CALCA—thyroid cancer	0.0076	0.0178	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00748	0.0176	CbGpPWpGaD
Misoprostol—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.0067	0.0146	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CALCB—thyroid cancer	0.00654	0.0153	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—CALCA—thyroid cancer	0.00624	0.0146	CbGpPWpGaD
Misoprostol—Dehydration—Vandetanib—thyroid cancer	0.00623	0.0136	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CALCB—thyroid cancer	0.00603	0.0142	CbGpPWpGaD
Misoprostol—Neuropathy—Sorafenib—thyroid cancer	0.00584	0.0127	CcSEcCtD
Misoprostol—Dysphagia—Vandetanib—thyroid cancer	0.00579	0.0126	CcSEcCtD
Misoprostol—Bronchospasm—Vandetanib—thyroid cancer	0.00569	0.0124	CcSEcCtD
Misoprostol—Bronchitis—Vandetanib—thyroid cancer	0.00557	0.0121	CcSEcCtD
Misoprostol—Dysuria—Vandetanib—thyroid cancer	0.00541	0.0118	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00538	0.0117	CcSEcCtD
Misoprostol—Pneumonia—Vandetanib—thyroid cancer	0.00519	0.0113	CcSEcCtD
Misoprostol—Conjunctivitis—Vandetanib—thyroid cancer	0.00502	0.0109	CcSEcCtD
Misoprostol—Urinary tract infection—Vandetanib—thyroid cancer	0.00502	0.0109	CcSEcCtD
Misoprostol—Haematuria—Vandetanib—thyroid cancer	0.00492	0.0107	CcSEcCtD
Misoprostol—Epistaxis—Vandetanib—thyroid cancer	0.00487	0.0106	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00484	0.0114	CbGpPWpGaD
Misoprostol—Rectal disorder—Epirubicin—thyroid cancer	0.00469	0.0102	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CALCB—thyroid cancer	0.0045	0.0106	CbGpPWpGaD
Misoprostol—Visual impairment—Vandetanib—thyroid cancer	0.00447	0.00972	CcSEcCtD
Misoprostol—Anorectal disorder—Epirubicin—thyroid cancer	0.00438	0.00952	CcSEcCtD
Misoprostol—Rectal disorder—Doxorubicin—thyroid cancer	0.00434	0.00944	CcSEcCtD
Misoprostol—Dehydration—Sorafenib—thyroid cancer	0.0042	0.00914	CcSEcCtD
Misoprostol—Arrhythmia—Vandetanib—thyroid cancer	0.00414	0.00901	CcSEcCtD
Misoprostol—Alopecia—Vandetanib—thyroid cancer	0.00409	0.00891	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CALCB—thyroid cancer	0.00409	0.00959	CbGpPWpGaD
Misoprostol—Breast disorder—Sorafenib—thyroid cancer	0.00408	0.00889	CcSEcCtD
Misoprostol—Anorectal disorder—Doxorubicin—thyroid cancer	0.00405	0.00881	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00397	0.00933	CbGpPWpGaD
Misoprostol—Dysphagia—Sorafenib—thyroid cancer	0.00391	0.0085	CcSEcCtD
Misoprostol—Muscle spasms—Vandetanib—thyroid cancer	0.00388	0.00844	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00376	0.00883	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CALCB—thyroid cancer	0.00369	0.00867	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—TSHR—thyroid cancer	0.00369	0.00865	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00367	0.00861	CbGpPWpGaD
Misoprostol—Erectile dysfunction—Sorafenib—thyroid cancer	0.0036	0.00783	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—SST—thyroid cancer	0.00359	0.00842	CbGpPWpGaD
Misoprostol—Embolism—Epirubicin—thyroid cancer	0.00358	0.0078	CcSEcCtD
Misoprostol—Loss of consciousness—Vandetanib—thyroid cancer	0.00355	0.00772	CcSEcCtD
Misoprostol—Pneumonia—Sorafenib—thyroid cancer	0.0035	0.00762	CcSEcCtD
Misoprostol—Hypertension—Vandetanib—thyroid cancer	0.00348	0.00758	CcSEcCtD
Misoprostol—Arthralgia—Vandetanib—thyroid cancer	0.00343	0.00747	CcSEcCtD
Misoprostol—Chest pain—Vandetanib—thyroid cancer	0.00343	0.00747	CcSEcCtD
Misoprostol—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00343	0.00747	CcSEcCtD
Misoprostol—Anxiety—Vandetanib—thyroid cancer	0.00342	0.00745	CcSEcCtD
Misoprostol—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00341	0.00743	CcSEcCtD
Misoprostol—Myocardial infarction—Sorafenib—thyroid cancer	0.00341	0.00743	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CALCB—thyroid cancer	0.00341	0.008	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CALCB—thyroid cancer	0.00335	0.00787	CbGpPWpGaD
Misoprostol—Embolism—Doxorubicin—thyroid cancer	0.00332	0.00722	CcSEcCtD
Misoprostol—Oedema—Vandetanib—thyroid cancer	0.00329	0.00716	CcSEcCtD
Misoprostol—Epistaxis—Sorafenib—thyroid cancer	0.00328	0.00715	CcSEcCtD
Misoprostol—Infection—Vandetanib—thyroid cancer	0.00327	0.00712	CcSEcCtD
Misoprostol—Thrombocytopenia—Vandetanib—thyroid cancer	0.00322	0.00701	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—PTCH1—thyroid cancer	0.00313	0.00735	CbGpPWpGaD
Misoprostol—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.00311	0.00676	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CALCB—thyroid cancer	0.0031	0.00727	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00309	0.00725	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—TSHR—thyroid cancer	0.00303	0.0071	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.003	0.00653	CcSEcCtD
Misoprostol—Dyspnoea—Vandetanib—thyroid cancer	0.00294	0.00639	CcSEcCtD
Misoprostol—Gingivitis—Epirubicin—thyroid cancer	0.00293	0.00638	CcSEcCtD
Misoprostol—Tinnitus—Sorafenib—thyroid cancer	0.00291	0.00634	CcSEcCtD
Misoprostol—Dyspepsia—Vandetanib—thyroid cancer	0.0029	0.00631	CcSEcCtD
Misoprostol—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00288	0.00626	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—SST—thyroid cancer	0.00287	0.00673	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00285	0.00669	CbGpPWpGaD
Misoprostol—Glycosuria—Epirubicin—thyroid cancer	0.00284	0.00618	CcSEcCtD
Misoprostol—Fatigue—Vandetanib—thyroid cancer	0.00284	0.00618	CcSEcCtD
Misoprostol—Immune system disorder—Sorafenib—thyroid cancer	0.00282	0.00614	CcSEcCtD
Misoprostol—Rigors—Epirubicin—thyroid cancer	0.00282	0.00613	CcSEcCtD
Misoprostol—Constipation—Vandetanib—thyroid cancer	0.00282	0.00613	CcSEcCtD
Misoprostol—Pain—Vandetanib—thyroid cancer	0.00282	0.00613	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—TSHR—thyroid cancer	0.00279	0.00656	CbGpPWpGaD
Misoprostol—Arrhythmia—Sorafenib—thyroid cancer	0.00279	0.00608	CcSEcCtD
Misoprostol—Alopecia—Sorafenib—thyroid cancer	0.00276	0.00601	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CALCA—thyroid cancer	0.00276	0.00648	CbGpPWpGaD
Misoprostol—Gingivitis—Doxorubicin—thyroid cancer	0.00271	0.0059	CcSEcCtD
Misoprostol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00269	0.00586	CcSEcCtD
Misoprostol—Breast pain—Epirubicin—thyroid cancer	0.00264	0.00574	CcSEcCtD
Misoprostol—Glycosuria—Doxorubicin—thyroid cancer	0.00263	0.00572	CcSEcCtD
Misoprostol—Muscle spasms—Sorafenib—thyroid cancer	0.00262	0.00569	CcSEcCtD
Misoprostol—Rigors—Doxorubicin—thyroid cancer	0.00261	0.00567	CcSEcCtD
Misoprostol—Body temperature increased—Vandetanib—thyroid cancer	0.0026	0.00566	CcSEcCtD
Misoprostol—Abdominal pain—Vandetanib—thyroid cancer	0.0026	0.00566	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—PTCH1—thyroid cancer	0.00257	0.00604	CbGpPWpGaD
Misoprostol—Anaemia—Sorafenib—thyroid cancer	0.00251	0.00547	CcSEcCtD
Misoprostol—Syncope—Sorafenib—thyroid cancer	0.00244	0.00531	CcSEcCtD
Misoprostol—Breast pain—Doxorubicin—thyroid cancer	0.00244	0.00531	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CALCB—thyroid cancer	0.00241	0.00566	CbGpPWpGaD
Misoprostol—Loss of consciousness—Sorafenib—thyroid cancer	0.00239	0.0052	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—PTCH1—thyroid cancer	0.00237	0.00557	CbGpPWpGaD
Misoprostol—Inflammation—Epirubicin—thyroid cancer	0.00237	0.00516	CcSEcCtD
Misoprostol—Asthenia—Vandetanib—thyroid cancer	0.00236	0.00514	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—SST—thyroid cancer	0.00235	0.00552	CbGpPWpGaD
Misoprostol—Hypertension—Sorafenib—thyroid cancer	0.00235	0.00511	CcSEcCtD
Misoprostol—Myalgia—Sorafenib—thyroid cancer	0.00232	0.00504	CcSEcCtD
Misoprostol—Arthralgia—Sorafenib—thyroid cancer	0.00232	0.00504	CcSEcCtD
Misoprostol—Pulmonary embolism—Epirubicin—thyroid cancer	0.0023	0.00501	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.0023	0.00501	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TRIM33—thyroid cancer	0.00229	0.00537	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CALCA—thyroid cancer	0.00227	0.00532	CbGpPWpGaD
Misoprostol—Diarrhoea—Vandetanib—thyroid cancer	0.00225	0.0049	CcSEcCtD
Misoprostol—Anaphylactic shock—Sorafenib—thyroid cancer	0.00222	0.00483	CcSEcCtD
Misoprostol—Infection—Sorafenib—thyroid cancer	0.00221	0.0048	CcSEcCtD
Misoprostol—Inflammation—Doxorubicin—thyroid cancer	0.00219	0.00478	CcSEcCtD
Misoprostol—Shock—Sorafenib—thyroid cancer	0.00218	0.00475	CcSEcCtD
Misoprostol—Dizziness—Vandetanib—thyroid cancer	0.00218	0.00474	CcSEcCtD
Misoprostol—Thrombocytopenia—Sorafenib—thyroid cancer	0.00217	0.00473	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—SST—thyroid cancer	0.00217	0.0051	CbGpPWpGaD
Misoprostol—Neuropathy—Epirubicin—thyroid cancer	0.00216	0.0047	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00213	0.00463	CcSEcCtD
Misoprostol—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00213	0.00463	CcSEcCtD
Misoprostol—Vomiting—Vandetanib—thyroid cancer	0.00209	0.00456	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CALCA—thyroid cancer	0.00209	0.00491	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—TSHR—thyroid cancer	0.00208	0.00489	CbGpPWpGaD
Misoprostol—Rash—Vandetanib—thyroid cancer	0.00208	0.00452	CcSEcCtD
Misoprostol—Dermatitis—Vandetanib—thyroid cancer	0.00207	0.00451	CcSEcCtD
Misoprostol—Headache—Vandetanib—thyroid cancer	0.00206	0.00449	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00202	0.0044	CcSEcCtD
Misoprostol—Abnormal vision—Epirubicin—thyroid cancer	0.00201	0.00437	CcSEcCtD
Misoprostol—Neuropathy—Doxorubicin—thyroid cancer	0.002	0.00435	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CALCB—thyroid cancer	0.00198	0.00465	CbGpPWpGaD
Misoprostol—Dyspnoea—Sorafenib—thyroid cancer	0.00198	0.00431	CcSEcCtD
Misoprostol—Nausea—Vandetanib—thyroid cancer	0.00196	0.00426	CcSEcCtD
Misoprostol—Dyspepsia—Sorafenib—thyroid cancer	0.00195	0.00425	CcSEcCtD
Misoprostol—Phlebitis—Epirubicin—thyroid cancer	0.00194	0.00422	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00192	0.00418	CcSEcCtD
Misoprostol—Fatigue—Sorafenib—thyroid cancer	0.00191	0.00417	CcSEcCtD
Misoprostol—Constipation—Sorafenib—thyroid cancer	0.0019	0.00413	CcSEcCtD
Misoprostol—Pain—Sorafenib—thyroid cancer	0.0019	0.00413	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—TSHR—thyroid cancer	0.00189	0.00444	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TRIM33—thyroid cancer	0.00188	0.00441	CbGpPWpGaD
Misoprostol—Vascular purpura—Epirubicin—thyroid cancer	0.00187	0.00406	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00186	0.00437	CbGpPWpGaD
Misoprostol—Abnormal vision—Doxorubicin—thyroid cancer	0.00186	0.00404	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CALCB—thyroid cancer	0.00183	0.00429	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00182	0.00395	CcSEcCtD
Misoprostol—Phlebitis—Doxorubicin—thyroid cancer	0.00179	0.0039	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00178	0.00387	CcSEcCtD
Misoprostol—Body temperature increased—Sorafenib—thyroid cancer	0.00176	0.00382	CcSEcCtD
Misoprostol—Abdominal pain—Sorafenib—thyroid cancer	0.00176	0.00382	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—TRIM33—thyroid cancer	0.00173	0.00407	CbGpPWpGaD
Misoprostol—Purpura—Epirubicin—thyroid cancer	0.00173	0.00377	CcSEcCtD
Misoprostol—Vascular purpura—Doxorubicin—thyroid cancer	0.00173	0.00376	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—TSHR—thyroid cancer	0.00171	0.00401	CbGpPWpGaD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00167	0.00363	CcSEcCtD
Misoprostol—Hypersensitivity—Sorafenib—thyroid cancer	0.00164	0.00356	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—SST—thyroid cancer	0.00162	0.0038	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PTCH1—thyroid cancer	0.00161	0.00377	CbGpPWpGaD
Misoprostol—Purpura—Doxorubicin—thyroid cancer	0.0016	0.00349	CcSEcCtD
Misoprostol—Asthenia—Sorafenib—thyroid cancer	0.00159	0.00347	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—TSHR—thyroid cancer	0.00158	0.0037	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CALCA—thyroid cancer	0.00156	0.00366	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—TSHR—thyroid cancer	0.00155	0.00365	CbGpPWpGaD
Misoprostol—Dehydration—Epirubicin—thyroid cancer	0.00155	0.00338	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00155	0.00336	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00153	0.00359	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TCF7L1—thyroid cancer	0.00153	0.00358	CbGpPWpGaD
Misoprostol—Diarrhoea—Sorafenib—thyroid cancer	0.00152	0.00331	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—thyroid cancer	0.00151	0.00328	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—SST—thyroid cancer	0.00147	0.00345	CbGpPWpGaD
Misoprostol—Dizziness—Sorafenib—thyroid cancer	0.00147	0.0032	CcSEcCtD
Misoprostol—Dysphagia—Epirubicin—thyroid cancer	0.00144	0.00314	CcSEcCtD
Misoprostol—Dehydration—Doxorubicin—thyroid cancer	0.00144	0.00313	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—TSHR—thyroid cancer	0.00143	0.00336	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CALCA—thyroid cancer	0.00142	0.00332	CbGpPWpGaD
Misoprostol—Vomiting—Sorafenib—thyroid cancer	0.00141	0.00307	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00141	0.00331	CbGpPWpGaD
Misoprostol—Rash—Sorafenib—thyroid cancer	0.0014	0.00305	CcSEcCtD
Misoprostol—Dermatitis—Sorafenib—thyroid cancer	0.0014	0.00304	CcSEcCtD
Misoprostol—Breast disorder—Doxorubicin—thyroid cancer	0.0014	0.00304	CcSEcCtD
Misoprostol—Headache—Sorafenib—thyroid cancer	0.00139	0.00303	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—thyroid cancer	0.00139	0.00302	CcSEcCtD
Misoprostol—Dysuria—Epirubicin—thyroid cancer	0.00135	0.00294	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00134	0.00292	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—thyroid cancer	0.00134	0.00291	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—SST—thyroid cancer	0.00133	0.00312	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PTCH1—thyroid cancer	0.00132	0.0031	CbGpPWpGaD
Misoprostol—Nausea—Sorafenib—thyroid cancer	0.00132	0.00287	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—thyroid cancer	0.00129	0.00282	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—thyroid cancer	0.00129	0.0028	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—thyroid cancer	0.00128	0.00279	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CDK1—thyroid cancer	0.00128	0.00301	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CALCA—thyroid cancer	0.00128	0.003	CbGpPWpGaD
Misoprostol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00126	0.00275	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TCF7L1—thyroid cancer	0.00125	0.00294	CbGpPWpGaD
Misoprostol—Conjunctivitis—Epirubicin—thyroid cancer	0.00125	0.00272	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—thyroid cancer	0.00125	0.00272	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—thyroid cancer	0.00125	0.00272	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00124	0.0027	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—SST—thyroid cancer	0.00123	0.00288	CbGpPWpGaD
Misoprostol—Haematuria—Epirubicin—thyroid cancer	0.00123	0.00267	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PTCH1—thyroid cancer	0.00122	0.00286	CbGpPWpGaD
Misoprostol—Epistaxis—Epirubicin—thyroid cancer	0.00121	0.00264	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—SST—thyroid cancer	0.00121	0.00283	CbGpPWpGaD
Misoprostol—Pneumonia—Doxorubicin—thyroid cancer	0.0012	0.00261	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—thyroid cancer	0.00119	0.00259	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CALCA—thyroid cancer	0.00118	0.00277	CbGpPWpGaD
Misoprostol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00117	0.00254	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CALCA—thyroid cancer	0.00116	0.00273	CbGpPWpGaD
Misoprostol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00116	0.00252	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—thyroid cancer	0.00116	0.00252	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—TCF7L1—thyroid cancer	0.00116	0.00272	CbGpPWpGaD
Misoprostol—Haematuria—Doxorubicin—thyroid cancer	0.00114	0.00247	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—thyroid cancer	0.00112	0.00244	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TSHR—thyroid cancer	0.00112	0.00262	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—SST—thyroid cancer	0.00111	0.00262	CbGpPWpGaD
Misoprostol—Visual impairment—Epirubicin—thyroid cancer	0.00111	0.00242	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PRKAR1A—thyroid cancer	0.0011	0.00258	CbGpPWpGaD
Misoprostol—Tinnitus—Epirubicin—thyroid cancer	0.00108	0.00234	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CALCA—thyroid cancer	0.00107	0.00252	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CDK1—thyroid cancer	0.00105	0.00247	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MEN1—thyroid cancer	0.00105	0.00247	CbGpPWpGaD
Misoprostol—Immune system disorder—Epirubicin—thyroid cancer	0.00104	0.00227	CcSEcCtD
Misoprostol—Chills—Epirubicin—thyroid cancer	0.00104	0.00226	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—thyroid cancer	0.00103	0.00225	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—thyroid cancer	0.00103	0.00224	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—thyroid cancer	0.00102	0.00222	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—thyroid cancer	0.000997	0.00217	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—thyroid cancer	0.000991	0.00216	CcSEcCtD
Misoprostol—Back pain—Epirubicin—thyroid cancer	0.000973	0.00212	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CDK1—thyroid cancer	0.000971	0.00228	CbGpPWpGaD
Misoprostol—Muscle spasms—Epirubicin—thyroid cancer	0.000967	0.0021	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—thyroid cancer	0.000965	0.0021	CcSEcCtD
Misoprostol—Chills—Doxorubicin—thyroid cancer	0.000959	0.00209	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—thyroid cancer	0.000955	0.00208	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PTCH1—thyroid cancer	0.00095	0.00223	CbGpPWpGaD
Misoprostol—Alopecia—Doxorubicin—thyroid cancer	0.000945	0.00206	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—thyroid cancer	0.000929	0.00202	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TSHR—thyroid cancer	0.000917	0.00215	CbGpPWpGaD
Misoprostol—Flatulence—Doxorubicin—thyroid cancer	0.000917	0.002	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000903	0.00212	CbGpPWpGaD
Misoprostol—Syncope—Epirubicin—thyroid cancer	0.000902	0.00196	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—thyroid cancer	0.0009	0.00196	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—thyroid cancer	0.000895	0.00195	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—thyroid cancer	0.000884	0.00192	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—SST—thyroid cancer	0.000869	0.00204	CbGpPWpGaD
Misoprostol—Hypertension—Epirubicin—thyroid cancer	0.000868	0.00189	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—MEN1—thyroid cancer	0.000863	0.00202	CbGpPWpGaD
Misoprostol—Anaemia—Doxorubicin—thyroid cancer	0.00086	0.00187	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—thyroid cancer	0.000856	0.00186	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—thyroid cancer	0.000856	0.00186	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—thyroid cancer	0.000856	0.00186	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—thyroid cancer	0.000853	0.00186	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—TSHR—thyroid cancer	0.000847	0.00199	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CALCA—thyroid cancer	0.000836	0.00196	CbGpPWpGaD
Misoprostol—Syncope—Doxorubicin—thyroid cancer	0.000834	0.00182	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000833	0.00196	CbGpPWpGaD
Misoprostol—Confusional state—Epirubicin—thyroid cancer	0.000828	0.0018	CcSEcCtD
Misoprostol—Oedema—Epirubicin—thyroid cancer	0.000821	0.00179	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—thyroid cancer	0.000821	0.00179	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000818	0.00178	CcSEcCtD
Misoprostol—Infection—Epirubicin—thyroid cancer	0.000815	0.00177	CcSEcCtD
Misoprostol—Shock—Epirubicin—thyroid cancer	0.000807	0.00176	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000804	0.00175	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—thyroid cancer	0.000803	0.00175	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—MEN1—thyroid cancer	0.000796	0.00187	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000793	0.00173	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—thyroid cancer	0.000792	0.00172	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—thyroid cancer	0.000792	0.00172	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—thyroid cancer	0.000792	0.00172	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—thyroid cancer	0.000789	0.00172	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PTCH1—thyroid cancer	0.00078	0.00183	CbGpPWpGaD
Misoprostol—Hypotension—Epirubicin—thyroid cancer	0.000767	0.00167	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—thyroid cancer	0.000766	0.00167	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—thyroid cancer	0.000759	0.00165	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000759	0.00165	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CDK1—thyroid cancer	0.000757	0.00178	CbGpPWpGaD
Misoprostol—Infection—Doxorubicin—thyroid cancer	0.000754	0.00164	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000748	0.00163	CcSEcCtD
Misoprostol—Shock—Doxorubicin—thyroid cancer	0.000747	0.00163	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000744	0.00162	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000734	0.0016	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—thyroid cancer	0.000732	0.00159	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—thyroid cancer	0.00073	0.00159	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—thyroid cancer	0.000722	0.00157	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PTCH1—thyroid cancer	0.00072	0.00169	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SST—thyroid cancer	0.000714	0.00167	CbGpPWpGaD
Misoprostol—Hypotension—Doxorubicin—thyroid cancer	0.00071	0.00154	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—thyroid cancer	0.000708	0.00154	CcSEcCtD
Misoprostol—Pain—Epirubicin—thyroid cancer	0.000702	0.00153	CcSEcCtD
Misoprostol—Constipation—Epirubicin—thyroid cancer	0.000702	0.00153	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000692	0.00151	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CALCA—thyroid cancer	0.000687	0.00161	CbGpPWpGaD
Misoprostol—Dyspnoea—Doxorubicin—thyroid cancer	0.000677	0.00147	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—thyroid cancer	0.000676	0.00147	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—thyroid cancer	0.000675	0.00147	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000671	0.00146	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—thyroid cancer	0.000668	0.00145	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—SST—thyroid cancer	0.000658	0.00155	CbGpPWpGaD
Misoprostol—Fatigue—Doxorubicin—thyroid cancer	0.000655	0.00142	CcSEcCtD
Misoprostol—Pain—Doxorubicin—thyroid cancer	0.000649	0.00141	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—thyroid cancer	0.000649	0.00141	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—thyroid cancer	0.000649	0.00141	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—thyroid cancer	0.000649	0.00141	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CALCA—thyroid cancer	0.000634	0.00149	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000626	0.00136	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CDK1—thyroid cancer	0.000622	0.00146	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000621	0.00135	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—NRG1—thyroid cancer	0.000608	0.00143	CbGpPWpGaD
Misoprostol—Hypersensitivity—Epirubicin—thyroid cancer	0.000605	0.00132	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—thyroid cancer	0.0006	0.00131	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—thyroid cancer	0.0006	0.00131	CcSEcCtD
Misoprostol—Asthenia—Epirubicin—thyroid cancer	0.000589	0.00128	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CDK1—thyroid cancer	0.000574	0.00135	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—thyroid cancer	0.000562	0.00122	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000559	0.00122	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TERT—thyroid cancer	0.000546	0.00128	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—thyroid cancer	0.000545	0.00119	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—thyroid cancer	0.000543	0.00118	CcSEcCtD
Misoprostol—Vomiting—Epirubicin—thyroid cancer	0.000522	0.00114	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—HIF1A—thyroid cancer	0.000522	0.00122	CbGpPWpGaD
Misoprostol—Diarrhoea—Doxorubicin—thyroid cancer	0.00052	0.00113	CcSEcCtD
Misoprostol—Rash—Epirubicin—thyroid cancer	0.000517	0.00113	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—thyroid cancer	0.000517	0.00113	CcSEcCtD
Misoprostol—Headache—Epirubicin—thyroid cancer	0.000514	0.00112	CcSEcCtD
Misoprostol—Dizziness—Doxorubicin—thyroid cancer	0.000502	0.00109	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—NRG1—thyroid cancer	0.000499	0.00117	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—thyroid cancer	0.000487	0.00106	CcSEcCtD
Misoprostol—Vomiting—Doxorubicin—thyroid cancer	0.000483	0.00105	CcSEcCtD
Misoprostol—Rash—Doxorubicin—thyroid cancer	0.000479	0.00104	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—thyroid cancer	0.000478	0.00104	CcSEcCtD
Misoprostol—Headache—Doxorubicin—thyroid cancer	0.000476	0.00104	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—NRG1—thyroid cancer	0.000461	0.00108	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—NRAS—thyroid cancer	0.00046	0.00108	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—thyroid cancer	0.000451	0.000982	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TERT—thyroid cancer	0.000448	0.00105	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BRAF—thyroid cancer	0.000432	0.00101	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HIF1A—thyroid cancer	0.000429	0.00101	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—thyroid cancer	0.000414	0.000971	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—thyroid cancer	0.000396	0.000929	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HIF1A—thyroid cancer	0.000395	0.000928	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—NRAS—thyroid cancer	0.000378	0.000886	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BRAF—thyroid cancer	0.000355	0.000833	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—NRAS—thyroid cancer	0.000348	0.000818	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—thyroid cancer	0.000336	0.000789	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BRAF—thyroid cancer	0.000327	0.000769	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—thyroid cancer	0.000327	0.000767	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—thyroid cancer	0.000325	0.000763	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—thyroid cancer	0.000315	0.00074	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—thyroid cancer	0.000304	0.000714	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—thyroid cancer	0.0003	0.000704	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—thyroid cancer	0.000297	0.000697	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—thyroid cancer	0.000276	0.000648	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NRAS—thyroid cancer	0.000272	0.000637	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—thyroid cancer	0.000269	0.00063	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—thyroid cancer	0.000259	0.000608	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—thyroid cancer	0.000255	0.000598	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—thyroid cancer	0.00025	0.000587	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—thyroid cancer	0.000248	0.000582	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—thyroid cancer	0.000244	0.000572	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—thyroid cancer	0.000239	0.000561	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—thyroid cancer	0.000234	0.000549	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—thyroid cancer	0.000231	0.000541	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—thyroid cancer	0.000225	0.000528	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NRAS—thyroid cancer	0.000223	0.000523	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—thyroid cancer	0.000208	0.000488	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NRAS—thyroid cancer	0.000206	0.000483	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—thyroid cancer	0.000199	0.000466	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—thyroid cancer	0.000192	0.00045	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—thyroid cancer	0.000177	0.000416	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—thyroid cancer	0.000175	0.000412	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—thyroid cancer	0.000171	0.0004	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—thyroid cancer	0.000163	0.000383	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—thyroid cancer	0.000157	0.00037	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—thyroid cancer	0.000151	0.000353	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—thyroid cancer	0.000144	0.000338	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—thyroid cancer	0.000133	0.000312	CbGpPWpGaD
